Prostate Biopsy Outcome in Active Surveillance Tied to PSA Kinetics
Providers should biopsy patients who are on active surveillance for prostate cancer on a regular schedule, according to investigators.
Providers should biopsy patients who are on active surveillance for prostate cancer on a regular schedule, according to investigators.
In a large study of men with grade group 2 or 3 prostate cancer, cancer-specific mortality at 8 years was high at 6% and 11% for active surveillance and watchful waiting patients, respectively.
A study of American men showed that those who adhered to a low-fat diet were twice as likely as men consuming usual diets to have hypogonadism.
By 3 and 6 months, flow rate, post void residual, IPSS, quality of life, and prostate volume improved in patients treated with the Rezum system, which uses convective heating to ablate prostate tissue.
Urinary stasis and other factors appear to play a role in its pathogenesis.
In real-world practice, patients older than 65 taking abiraterone or enzalutamide were more likely to experience cardiac disorders, such as atrial fibrillation, than their younger counterparts.
In a study, radiation delivered to the primary prostate tumor in men with metastatic castration-resistant prostate cancer was associated with a 74% decreased risk of death from any cause.
From 2004 to 2014, the annual number of cases of ureteroscopy increased significantly from 9601 to 12,087.
Annual stone incidence increased from 0.6% in 2005 to 0.9% in 2015.
In a small study of radical cystectomy patients, perioperative hypogonadism persisted up to 90 days after surgery.